Polymer based dosages form the mainstay of drug delivery systems either as simple matrix carrier materials or active release behaviour modulating agents. In addition, several techniques have been developed further to deliver novel polymeric structures. One such method is electrospinning (ES); a maturing process which is operational at the ambient environment and enables drug loading (in molecularly dispersed form) directly into a fibrous polymer matrix system. Since there is an impending need to address healthcare challenges arising from an increase in the aging population (requiring enhanced treatments), the ES method was used to develop fibrous polymer composite-indomethacin ( 
Microscopic imaging and size distribution
Scanning electron microscopy (SEM) was performed using a SEM Carl Zeiss EVO ® HD15
(Carl, Zeiss, Oberkochen, Germany). Fibres were mounted onto the sample holder (aluminium stub) using double sided tape. To prevent any overcharging, samples were covered with a thin film of gold by sputter coating (S150B, Edwards, Crawley, West Sussex, UK). Micrographs were examined and fibre diameters were analysed via SEM program Image Tool. The mean fibre diameter distribution and range was determined using 150 random measurements from each sample (assumed to be representative fibre morphology).
X-ray diffraction studies (XRD)
Sample crystallinity was evaluated with XRD analysis performed on a BrukerD8-Advance diffractometer, operating at 40 kV and 40 mA, using Cu Ka1, at a scanning rate of 0.35 sec/step. Spectra were collected in the 20 angle from 10-50˚.
Differential scanning calorimetry (DSC)
DSC analysis was performed using a PerkinElmer Jade DSC differential scanning calorimeter (PerkinElmer Ltd., Shelton, CT, USA). Samples (3.5 -4.2 mg) were placed into an aluminium pan (Perkin Elmer) and sealed. Samples were heated from 20 to 200 °C at a heating rate of 10°C/min under a nitrogen purge of 70 mL/min.
Thermogravimetric analysis (TGA)
Thermal behaviour of prepared fibres was analysed using a thermal gravimetric analyser TGA (Perkin Elmer Pyris 1 TGA). Each sample was placed in an aluminium pan (TGA, Perkin Elmer), weighted (7-10 mg) and heated at a temperature range of 20 to 800°C in a nitrogen atmosphere, using heating rate of 10 °C/min.
Fourier Transform infra-red spectroscopy (FTIR)
The chemical structure of raw materials and prepared fibres was analysed using a Fourier
Transform Infrared spectrophotometer (FTIR Platinum-ATR fitted with Bruker Alpha Opus 27 FT-IR). Infrared spectra were recorded in the range 4000 -400 cm −1 , obtained using an average 30 scans at a resolution of 4 cm -1 for each sample.
Raman spectroscopy
Raman spectra were obtained using a FORAM ® Raman spectrometer (Foster & Freeman Ltd) equipped with a 785 nm laser; accumulating 30 scans at 4 cm -1 resolution. Raman spectra were collected between 3300 and 100 cm -1 .
Contact angle measurements
Phosphate buffer (PBS, pH 6.8) contact angles on fibrous films were measured using "Theta light" (Biolin Scientific Attension, Stockholm, Sweden) contact angle measuring equipment.
Formulations were electrospun onto glass slides for ~ 30 mins and then placed on the testing plate. Thereafter, PBS was micro-pipetted onto the films surface. Dynamic contact angles
were assessed using a video monitor. Each sample was measured three times.
PBS-Film contact time behavior
Selected film formulations were electropsun directly onto glass slides using parameters determined during engineering. Glass coated slides were then immersed into PBS solution for known time intervals and removed. Subsequently, all residual PBS was rapidly dripped off from the substrate (through tilting mechanism) and films were allowed to dry for 48 h.
Samples were then analyzed using SEM for changes to fibre structure, integrity and potential precipitation effects.
Drug loading capacity
Precisely weighted amount (1 mg) of all samples was dissolved in 3 mL of ethanol in capped glass vials under magnetic stirring for 15 min to ensure complete dissolution. The resulting solutions were centrifuged at 4,500 rpm for 15 min, and quantification of INDO was performed on the resulting supernatants using UV-Vis analysis at 320nm (UV-Vis spectrophotometer, Shimadzu, UVmini-1240). Experiments were run in triplicate. Drug content was calculated according to the following equation [37] . 
where Q is the amount of drug released in time t and K H is the Higuchi dissolution constant.
Ex-vivo buccal permeation
Porcine mucosal specimens (from a local slaughterhouse in Thessaloniki) were obtained from tissue removed from the inner cheek (buccal area) of freshly slaughtered pigs. After sampling, all specimens transferred to laboratory in ice-cold buffer (PBS) within 1 h.
Specimens were surgically treated to remove excesses of connective and adipose tissue until slides 700 ±100 μm. In all experiments, the drug transferred from the donor to the acceptor compartment was 
Analysis of permeation data
The steady state flux (J ss ) across the epithelium were calculated using the following equation
where Q is the cumulative amount of drug penetrating the mucosa (μg), A is the diffusional area (cm 2 ) and t is the total time of the experiment (h).
The permeability coefficient (P) was then calculated by the relationship [41] 
where Cd is the drug concentration in the donor compartment (μg/cm 3 ).
Histological evaluation
Abnormalities of the mucosal architecture after transport studies were evaluated using 4 μm-thick sections of each of the formalin-fixed and paraffin-embedded samples stained by conventional hematoxylin-eosin. Specimens were analyzed in an Olympus CX31 optical microscope and microphotographs were taken via the OLYMPUS analysis getIT software.
Statistical analysis
Differences in transport studies were evaluated by unpaired t-test. A one-way analysis of variance with Dunnett's multiple comparison test was performed by comparing formulations against formulation F1. The data were considered significantly different when the p-value was less than 0.05.
Results and Discussion

Fibre morphology and size distribution
Fibrous membranes were engineered using all INDO (solution) formulations. Stable jetting was determined using a preliminary applied voltage vs. infusion rate experimental matrix to ensure near uniform fibre engineering. To achieve this stable jetting, several modes are encountered which become apparent for various types of media [42, 43] at the nozzle exit. In addition, various jetting modes have been developed based on material properties and needle alignment and these have an impact on the end structure [44, 45] . However, stable jetting windows were determined for INDO-PVP based formulations and were subsequently used to engineer fibrous films.
Figures 3a-e show surface morphology of various electrospun fibrous membranes with inset images displaying membrane width (thickness), obtained using horizontal and plan view microscopic analysis. All formulated fibres exhibit a smooth surface; albeit with variable diameter distributions. The difference is attributed to the inclusion of additional excipients and co-polymer ratios [8] . Figure 5a ). This melting peak is no longer observed for electrospun samples, indicating the drug is dispersed throughout the polymer matrix post ES. Numerous studies have made use of the ES technique to engineer PVP fibres from the raw polymer [47, 48, 49] .
In these, a broad endotherm arising at ~90 C has been reported which is also the case in this study for all samples prepared using INDO and PVP. The broad endotherm at this value is attributed to dehydration which is most likely due to loss of moisture often adsorbed by hygroscopic PVP polymer, the rate of which may be enhanced due to the increased surface area of fibrous structures. Furthermore, increasing the ES co-polymer formulation content provides greater polymeric matrix volume for active spacing and dispersion. Previous studies indicate similar degradation steps [51] .
TGA thermogram of PVP-INDO formulation (F1) shows the highest temperature associated
with the second weight-loss step when compared with all other fibrous formulations, which incorporates a co-polymer excipient into the fibrous drug loaded film. INDO is loaded directly into filamentous matrices [8] and previous studies report that a shift in the maximum temperature (associated weight-loss step) can be used to validate drug entrapment within films [51] . The thermal degradation of a composite formulation is also driven by the active ingredient (drug) used; as both increase and decrease in the maximum temperature associated weight loss have been shown [51] .
Fourier Transform Infrared (FTIR) and Raman spectroscopic analysis
Raman and FTIR spectroscopy were used to study structure and molecular conformation of fibrous films by probing band vibrations [52] . due to hydrogen bonding with the active and other co-polymers [53] . Although near identical peaks are observed between formulations and pristine samples, a new peak is observed between 1087-1113 cm − 1 , and is ascribed to carboxylic acid carbonyl stretching within copolymer molecules which may arise due to hydrogen bonding or Van der Waals forces.
Contact angle measurements
Contact angle measurements were used to assess film hydrophilicity as shown in 
Membrane -medium contact behavior
To investigate structural change to fibrous components when in contact with test medium;
pristine PVP fibres, PVP-INDO composite fibres and raw INDO powder was assessed using interfacing PBS medium. PVP fibres dissolved rapidly even at 1s and fibre integrity was compromised indicated by continuous threads transitioning into beaded structures (Figure   8b ), which then merge to form more coarse PVP particles. Inclusion of INDO into fibrous PVP matrices (Figure 8c) yield similar structures at the initial stage. When in contact with PBS, over designated time period, PVP dissolves leaving discrete PVP components.
However, an indication of INDO precipitation is suspected (Figure 8c ) with reduced PVP content; which eludes to the importance of both solubility (dispersion) and permeability. In comparison to raw INDO powder (Figure 8a) , precipitates forming from rapid solubilisation of PVP are much smaller and therefore provide a greater surface area for interaction (i.e. for further INDO solubility).
In vitro release studies Table 1 represents drug content in fibrous films which ranged from 2.89 to 4.93% w/w. The values are less than the theoretical maxim (5% w/w) incorporated into ES formulations prior to processing. This is due to drug precipitation during the ES process or shortly thereafter.
Moreover, samples prepared using co-polymer Methocel TM (E15) reveal greater drug encapsulation compared to Methocel TM (E5).
Cumulative release profiles of various INDO formulations are illustrated in Figure 9 (a & b) .
The presence of methyl cellulose results in a decrease in API release rate (formulations F2 & F3) compared to the single polymer-drug system (PVP-INDO, F1).Here, sustained release is attributed to the non-soluble nature of cellulose based components. However, the sustained effect is less well pronounced when Methocel TM (E5) is co-formulated in the film system. In this instance, 80 % of drug is released within 2h, whereas when prepared using its congener (Methocel TM (E15)) only 60 % of active is released. The higher release rate is linked to superior swelling behavior of Methocel™ (E5) arising from enhanced hydration rate, molecular mass and viscosity compared to Methocel™ (E15) [54] (viscosity of Methocel™ (E5) and Methocel™ (E15) is 4-6 and 12-18, respectively [55] ). The addition of non-ionic surfactant (Tween ® 80) has little notable effect on INDO release (formulations F4 & F5).
Higuchi kinetic model fitting was applied to in vitro drug release data (from engineered fibrous films). Drug release from all formulations showed two distinct release phases; an initial burst type release phase followed by a lag period. The Higuchi kinetic model fitting was applied to the initial phase. Correlation coefficient (R 2 ) and the release rate constant
14
(K) are shown as insets in Figures 9 (a and b) . All formulations show high linearity with R 2 (>0.92). It can be concluded that the dominating mechanism for INDO release is fickian diffusion. However, the release rate is different for each formulation; where F1 possessed the greatest K value and F5 possessed the lowest K value.
Transport studies
The cumulative permeation profiles of tested formulations are shown in Figure 10 . and 2 h for all the rest formulations was noticed which is likely to be attributed to the slow mucosal adhesion process.
Histological Evaluation
Light microscopy studies were performed to further assess any histological changes upon Tables   Table 1   FORMULATION 
F5 formulation (Magnification x100).
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